Cited 15 times in
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.